Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts. more
Time Frame | PULM | Sector | S&P500 |
---|---|---|---|
1-Week Return | -16.53% | 0.49% | -0.42% |
1-Month Return | 0.84% | -3.1% | -2.2% |
3-Month Return | 179.53% | -8.59% | 2.38% |
6-Month Return | 190.34% | -4.57% | 5.1% |
1-Year Return | 194.61% | -0.94% | 23.79% |
3-Year Return | -23.24% | 2.88% | 26.66% |
5-Year Return | -80.61% | 35.84% | 81.16% |
10-Year Return | -99.67% | 98.8% | 191.72% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 7.91M | 12.63M | 5.17M | 6.07M | 7.30M | [{"date":"2019-12-31","value":62.61,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":40.91,"profit":true},{"date":"2022-12-31","value":48.05,"profit":true},{"date":"2023-12-31","value":57.76,"profit":true}] |
Cost of Revenue | 12.85M | - | 15.38M | 1.54M | 15.52M | [{"date":"2019-12-31","value":82.77,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":99.12,"profit":true},{"date":"2022-12-31","value":9.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (4.93M) | 12.63M | (10.21M) | 6.07M | (8.22M) | [{"date":"2019-12-31","value":-39.06,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-80.84,"profit":false},{"date":"2022-12-31","value":48.05,"profit":true},{"date":"2023-12-31","value":-65.06,"profit":false}] |
Gross Margin | (62.39%) | 100.00% | (197.58%) | 100.00% | (112.63%) | [{"date":"2019-12-31","value":-62.39,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-197.58,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-112.63,"profit":false}] |
Operating Expenses | 21.33M | 22.50M | 21.76M | 25.02M | 22.04M | [{"date":"2019-12-31","value":85.27,"profit":true},{"date":"2020-12-31","value":89.92,"profit":true},{"date":"2021-12-31","value":86.97,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.09,"profit":true}] |
Operating Income | (20.69M) | (573.00K) | (20.17M) | (18.95M) | (14.74M) | [{"date":"2019-12-31","value":-2069200000,"profit":false},{"date":"2020-12-31","value":-57300000,"profit":false},{"date":"2021-12-31","value":-2016700000,"profit":false},{"date":"2022-12-31","value":-1894700000,"profit":false},{"date":"2023-12-31","value":-1474000000,"profit":false}] |
Total Non-Operating Income/Expense | 397.00K | (9.36M) | 3.00K | 420.00K | 1.49M | [{"date":"2019-12-31","value":26.73,"profit":true},{"date":"2020-12-31","value":-630.57,"profit":false},{"date":"2021-12-31","value":0.2,"profit":true},{"date":"2022-12-31","value":28.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (20.60M) | (19.31M) | (20.17M) | (18.84M) | (14.12M) | [{"date":"2019-12-31","value":-2059600000,"profit":false},{"date":"2020-12-31","value":-1930800000,"profit":false},{"date":"2021-12-31","value":-2017100000,"profit":false},{"date":"2022-12-31","value":-1883600000,"profit":false},{"date":"2023-12-31","value":-1412100000,"profit":false}] |
Income Taxes | (205.00K) | 9.21M | 2.33M | (111.00K) | 1.31M | [{"date":"2019-12-31","value":-2.23,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":25.35,"profit":true},{"date":"2022-12-31","value":-1.21,"profit":false},{"date":"2023-12-31","value":14.2,"profit":true}] |
Income After Taxes | (20.39M) | (28.52M) | (22.50M) | (18.73M) | (15.43M) | [{"date":"2019-12-31","value":-2039100000,"profit":false},{"date":"2020-12-31","value":-2851500000,"profit":false},{"date":"2021-12-31","value":-2250500000,"profit":false},{"date":"2022-12-31","value":-1872500000,"profit":false},{"date":"2023-12-31","value":-1542810500,"profit":false}] |
Income From Continuous Operations | (20.60M) | (19.31M) | (20.17M) | (18.84M) | (16.25M) | [{"date":"2019-12-31","value":-2059600000,"profit":false},{"date":"2020-12-31","value":-1930800000,"profit":false},{"date":"2021-12-31","value":-2017100000,"profit":false},{"date":"2022-12-31","value":-1883600000,"profit":false},{"date":"2023-12-31","value":-1625400000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (20.39M) | (28.52M) | (22.50M) | (18.73M) | (14.12M) | [{"date":"2019-12-31","value":-2039100000,"profit":false},{"date":"2020-12-31","value":-2851500000,"profit":false},{"date":"2021-12-31","value":-2250500000,"profit":false},{"date":"2022-12-31","value":-1872500000,"profit":false},{"date":"2023-12-31","value":-1412100000,"profit":false}] |
EPS (Diluted) | (27.60) | (7.40) | (8.63) | (5.46) | (3.86) | [{"date":"2019-12-31","value":-2760,"profit":false},{"date":"2020-12-31","value":-740,"profit":false},{"date":"2021-12-31","value":-863,"profit":false},{"date":"2022-12-31","value":-546,"profit":false},{"date":"2023-12-31","value":-386,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
PULM | |
---|---|
Cash Ratio | 18.27 |
Current Ratio | 19.40 |
Quick Ratio | 19.50 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PULM | |
---|---|
ROA (LTM) | -29.99% |
ROE (LTM) | -58.99% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PULM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.05 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.95 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PULM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.93 |
P/B | 2.01 |
Price/FCF | NM |
EV/R | 1.12 |
EV/Ebitda | 1.57 |
PEG | NM |
Pulmatrix Inc (PULM) share price today is $6.01
Yes, Indians can buy shares of Pulmatrix Inc (PULM) on Vested. To buy Pulmatrix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PULM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Pulmatrix Inc (PULM) via the Vested app. You can start investing in Pulmatrix Inc (PULM) with a minimum investment of $1.
You can invest in shares of Pulmatrix Inc (PULM) via Vested in three simple steps:
The 52-week high price of Pulmatrix Inc (PULM) is $8.44. The 52-week low price of Pulmatrix Inc (PULM) is $1.55.
The price-to-earnings (P/E) ratio of Pulmatrix Inc (PULM) is
The price-to-book (P/B) ratio of Pulmatrix Inc (PULM) is 2.01
The dividend yield of Pulmatrix Inc (PULM) is 0.00%
The market capitalization of Pulmatrix Inc (PULM) is $21.95M
The stock symbol (or ticker) of Pulmatrix Inc is PULM